Corient Private Wealth LP Invests $1.14 Million in Nutex Health Inc. $NUTX

Corient Private Wealth LP acquired a new stake in shares of Nutex Health Inc. (NASDAQ:NUTX) in the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 6,684 shares of the company’s stock, valued at approximately $1,142,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. Deutsche Bank AG raised its stake in Nutex Health by 3.9% during the 4th quarter. Deutsche Bank AG now owns 2,633 shares of the company’s stock valued at $433,000 after buying an additional 98 shares during the last quarter. Russell Investments Group Ltd. grew its holdings in shares of Nutex Health by 1.4% in the fourth quarter. Russell Investments Group Ltd. now owns 8,706 shares of the company’s stock worth $1,433,000 after acquiring an additional 116 shares during the period. Kilter Group LLC bought a new stake in shares of Nutex Health in the second quarter worth $27,000. VIRGINIA RETIREMENT SYSTEMS ET Al increased its position in Nutex Health by 3.7% during the fourth quarter. VIRGINIA RETIREMENT SYSTEMS ET Al now owns 5,600 shares of the company’s stock valued at $922,000 after acquiring an additional 200 shares during the last quarter. Finally, Allworth Financial LP purchased a new stake in Nutex Health during the second quarter valued at $35,000. 5.32% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Several research analysts have issued reports on the company. B. Riley Financial raised their target price on Nutex Health from $290.00 to $325.00 and gave the stock a “buy” rating in a research report on Friday. Wall Street Zen downgraded shares of Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday. B Riley reiterated a “buy” rating on shares of Nutex Health in a research report on Friday. Lake Street Capital restated a “buy” rating and issued a $310.00 price objective (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Finally, Weiss Ratings upgraded Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a research report on Tuesday, July 28th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and one has assigned a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Buy” and a consensus price target of $317.50.

Nutex Health Trading Down 2.2%

Shares of NUTX stock opened at $193.24 on Friday. The company has a debt-to-equity ratio of 0.59, a quick ratio of 4.96 and a current ratio of 5.00. The stock has a fifty day simple moving average of $175.59 and a two-hundred day simple moving average of $136.75. The firm has a market capitalization of $1.32 billion, a PE ratio of 7.59 and a beta of 0.28. Nutex Health Inc. has a 52-week low of $80.53 and a 52-week high of $204.00.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings data on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, topping analysts’ consensus estimates of $4.95 by $4.43. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%.The firm had revenue of $210.75 million during the quarter, compared to analyst estimates of $215.03 million.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.